Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;153(2):200-219.
doi: 10.1002/ijgo.13561. Epub 2021 Feb 22.

Physical methods for the treatment of genitourinary syndrome of menopause: A systematic review

Affiliations

Physical methods for the treatment of genitourinary syndrome of menopause: A systematic review

Ayane C A Sarmento et al. Int J Gynaecol Obstet. 2021 May.

Abstract

Background: Genitourinary syndrome of menopause (GSM) negatively affects sexual function and quality of life. Techniques like laser and radiofrequency are being used to manage GSM, particularly in women with contraindications for hormone therapy.

Objectives: To verify whether the physical methods of laser and radiofrequency can be recommended as safe and effective options for the treatment of GSM/urinary urgency or incontinence in pre- and postmenopausal women.

Search strategy: Databases were comprehensively searched using combinations of the following keywords in any language: "postmenopause"; "genitourinary syndrome of menopause"; "vaginal atrophy"; "radiofrequency"; and "laser."

Selection criteria: Full articles of case-control, cross-sectional, cohort, randomized clinical trials, and quasi-randomized or controlled clinical trials were included.

Data collection and analysis: All authors independently evaluated the design of the studies for quality of reporting, risk of bias, and quality of evidence.

Main results: Of the included 49 studies, 37 were on the CO2 laser, 10 on the Erbium laser, and two on radiofrequency.

Conclusions: Laser and radiofrequency therapy could be promising and safe therapeutic options for GSM/urinary incontinence. However, the study findings cannot be generalized until new randomized clinical trials are performed that confirm the strength of the evidence. This review has been registered with PROSPERO: CRD42020141913.

Keywords: atrophy; erbium; female urogenital diseases; laser therapy; menopause; radiofrequency.

PubMed Disclaimer

References

REFERENCES

    1. Politano CA, Costa-Paiva L, Aguiar LB, et al. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause. Menopause. 2019;26(8):833-840.
    1. Franić D, Fistonić I. Laser therapy in the treatment of female urinary incontinence and genitourinary syndrome of menopause: an update. Biomed Res Int. 2019;2019:1-9.
    1. Adabi K, Golshahi F, Niroomansh S, Razzaghi Z, Ghaemi M. Effect of the fractional CO2 laser on the quality of life, general health, and genitourinary symptoms in postmenopausal women with vaginal atrophy: a prospective cohort. J Lasers Med Sci. 2020;11(1):65-69.
    1. Pitsouni E, Grigoriadis T, Falagas ME, Salvatore S, Athanasiou S. Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis. Maturitas. 2017;10:78-88.
    1. Athanasiou S, Pitsouni E, Grigoriadis T, et al. Microablative fractional CO2 laser for the genitourinary syndrome of menopause. Menopause. 2018;26(3):248-255.

Publication types

LinkOut - more resources